Skip to main content

Table 2 Subjects’ clinical characteristics (mean ± SD)

From: Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease

 

Non-smokers

Smokers

COPD

F or χ2

p value

Female/male

0/10

0/10

0/20

–

–

Age (year),

62 ± 4.7

65 ± 5.6

65 ± 5.8

0.870

0.427

Smoking index (pack-years)

0

49.5 ± 18.3***

39.1 ± 23.5***

1.488b

0.233

Body mass index (BMI, kg/m2)

23.9 ± 3.6

21.6 ± 2.9

22.8 ± 2.7

1.245

0.300

FVC (%pred)

94.3 ± 17.6

90.0 ± 13.1

86.25 ± 11.8

1.169

0.322

FEV1 (%pred)

101.3 ± 12.2

92.0 ± 12.1

72.8 ± 11.9***##

21.163

< 0.001

FEV1/FVC

84.3 ± 6.0

77.0 ± 9.8

63.2 ± 6.7***###

30.323

< 0.001

FRC (%pred)

93.3 ± 21.6

113.1 ± 17.1

128.2 ± 27.0**

6.878

0.003

TLC (%pred)

113.3 ± 11.4

124.3 ± 12.6

129.0 ± 12.4**

5.123

0.011

DLCO (%pred)

115.5 ± 16.5

81.9 ± 11.8**

73.2 ± 24.6***

14.715

< 0.001

Pathology, Non-malignant/ Lung cancer

2/8

2/8

1/19

2.414a

0.264

CAT score, mild /moderate /severe

–

10/0/0

7/12/1##

12.101ab

0.001

mMRC classification, 0/1/2

–

6/4/0

9/10/1

0.969ab

0.800

  1. FVC%pred forced vital capacity percent predicted, FEV1%pred forced expiratory volume in one second percent predicted, FRC%pred functional residual volume percent predicted, TLC%pred total lung capacity percent predicted, DLCO%pred diffusing capacity of lung for carbon monoxide percent predicted, CAT COPD assessment test, mMRC modified Medical Research Council dyspnea score, VA alveolar volume
  2. aFisher exact test
  3. bCOPD vs. Smokers
  4. **p < 0.01
  5. ***p < 0.001 compared to non-smokers
  6. ##p < 0.01
  7. ###p < 0.001 compared to smokers